A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: Preliminary results of RTOG P-0019

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 3, 2006, Pages 804-809

  Lee, W Robert ^a   DeSilvio, Michelle ^b   Lawton, Colleen ^c   Gillin, Michael ^d   Morton, Gerard ^e   Firat, Selim ^f   Baikadi, Madhava ^f   Kuettel, Michael ^g   Greven, Kathryn ^a   Sandler, Howard ^h  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

125I; Morbidity; Multi institutional; Prostate brachytherapy

Indexed keywords

ONCOLOGY; PATIENT TREATMENT; TOXICITY;

125I; MORBIDITY; MULTI-INSTITUTIONAL; PROSTATE BRACHYTHERAPY;

RADIOTHERAPY;

IODINE 125;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION INJURY; UROGENITAL SYSTEM;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; GASTROINTESTINAL TRACT; HUMANS; IMPOTENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; UROGENITAL SYSTEM;

EID: 31844448946     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.09.002     Document Type: Article

References (28)

1. W.R. Lee, J. Moughan, J.B. Owen The 1999 patterns of care study of radiotherapy in localized prostate carcinoma A comprehensive survey of prostate brachytherapy in the United States Cancer 98 2003 1987 1994
2. D.Y. Gelblum, L. Potters, R. Ashley Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 45 1999 59 67
3. D.Y. Gelblum, L. Potters Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer Int J Radiat Oncol Biol Phys 48 2000 119 124
4. M. Ghaly, K. Wallner, G. Merrick The effect of supplemental beam radiation on prostate brachytherapy-related morbidity Morbidity outcomes from two prospective randomized multicenter trials Int J Radiat Oncol Biol Phys 55 2003 1288 1293
5. M. Albert, C.M. Tempany, D. Schultz Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy Cancer 98 2003 949 954
6. S.K. Kang, R.H. Chou, R.K. Dodge Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy Int J Radiat Oncol Biol Phys 53 2002 99 103
7. M.F. Sarosdy Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy Cancer 101 2004 754 760
8. J.C. Blasko, P.D. Grimm, J.E. Sylsvester The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma Radiother Oncol 57 2000 273 278
9. F.A. Critz, W.H. Williams, A.K. Levinson Simultaneous irradiation for prostate cancer Intermediate results with modern techniques J Urol 164 3 Pt 1 2000 738 741
10. M. Dattoli, K. Wallner, L. True Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma Influence of prostatic acid phosphatase Cancer 97 2003 979 983
11. J.A. Eastham, M.W. Kattan, S. Groshen Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer J Clin Oncol 15 1997 3214 3222
12. G.S. Merrick, W.M. Butler, R.W. Galbreath Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer Int J Radiat Oncol Biol Phys 51 2001 41 48
13. L. Potters, D. Huang, E. Calugaru Importance of implant dosimetry for patients undergoing prostate brachytherapy Urology 62 2003 1073 1077
14. H. Ragde, L.J. Korb, A.A. Elgamal Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up Cancer 89 2000 135 141
15. W.R. Lee, G.E. Hanks, A.L. Hanlon Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer Further evidence for a significant dose effect Int J Radiat Oncol Biol Phys 35 1996 251 257
16. R.M. Benoit, M.J. Naslund, J.K. Cohen Complications after prostate brachytherapy in the Medicare population Urology 55 2000 91 96
17. K. Wallner, J. Roy, L. Harrison Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 32 1995 465 471
18. M.J. Zelefsky, Y. Yamada, C. Marion Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy Int J Radiat Oncol Biol Phys 55 2003 956 963
19. G.S. Merrick, W.M. Butler, R.W. Galbreath Erectile function after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 52 2002 893 902
20. L. Potters, T. Torre, P.A. Fearn Potency after permanent prostate brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 50 2001 1235 1242
21. R.G. Stock, J. Kao, N.N. Stone Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer J Urol 165 2001 436 439
22. M.J. Zelefsky, T. Hollister, A. Raben Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 47 2000 1261 1266
23. D.S. Blander, R.F. Sanchez-Ortiz, G.A. Broderick Sex inventories Can questionnaires replace erectile dysfunction testing? Urology 54 1999 719 723
24. R.C. Rosen, J.C. Cappelleri, N. Gendrano III The International Index of Erectile Function (IIEF) A state-of-the-science review Int J Impot Res 14 2002 226 244
25. G.S. Merrick, W.M. Butler, K.E. Wallner The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction Int J Radiat Oncol Biol Phys 54 2002 1055 1062
26. M. Roach, K. Winter, J.M. Michalski Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406 Findings from a prospective, multi-institutional, phase I/II dose-escalation study Int J Radiat Oncol Biol Phys 60 2004 1351 1356
27. A.G. Wernicke, R. Valicenti, K. Dieva Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 60 2004 1357 1363
28. P.J. Eifel, C. Levenback, J.T. Wharton Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 32 1995 1289 1300